Digipath, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021
August 16, 2021 at 04:44 pm
Share
DigiPath, Inc. announced earnings results for the third quarter ended June 30, 2021. For the third quarter, the company announced sales was USD 764,015 compared to USD 407,229 a year ago. Operating loss was USD 146,084 compared to USD 471,878 a year ago. Net loss was USD 177,214 compared to USD 520,687 a year ago. For the nine months, sales was USD 1.897 million compared to USD 1.971 million a year ago. Operating loss was USD 491,728 compared to USD 1.278 million a year ago. Net loss was USD 549,650 compared to USD 1.350 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago.
Hypha Labs, Inc., formerly Digipath, Inc., has developed technology that cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes six-eight weeks to fully grow mushrooms, and using its technology, the production of the active ingredient is only seven-10 days. This natural product solves the dosing issue created by having to use whole mushrooms. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits. It provides Psilocybin Mushrooms, Button Mushrooms, Shiitake Mushrooms, Maitake Mushrooms, Reishi Mushrooms, Lion's Mane Mushrooms, Oyster Mushrooms, Oyster Mushrooms and Crimini Mushrooms.
HYPHA LABS, INC. 